期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

达卢生坦治疗顽固性高血压的临床研究进展 被引量：2

下载PDF
导出
摘要 顽固性高血压指凡服全剂量的3种或3种以上的不同作用机制的抗高血压药（必须包括一种全剂量利尿药），血压仍≥140／90mmHg、或24h动态血压（ABPM）日间平均血压≥128／83mmHg或24h动态血压≥125／80mmHg的高血压。顽固性高血压患者占全部高血压患者的30％，由于血压水平难以下降，而容易罹患心脏病和中风等疾病。
作者 雷兵团 白秋江 吴叶红
机构地区 华北煤炭医学院附属开滦医院
出处 《药物流行病学杂志》 CAS 2010年第5期294-296,共3页 Chinese Journal of Pharmacoepidemiology
关键词 达卢生坦 内皮素 顽固性高血压
分类号 R972.4 [医药卫生—药品]
  • 相关文献

参考文献15

  • 1Black HR. Management of patients with refractory hypertension[ M]. 2nd ed. AHA, 1999. 354-357.
  • 2Vidt DG. Resistant Hypertension [ A ]. in : Oparil S. Hyperten A companion to Brenner and vector. The kidney [ M ]. W. B. Saunders Company,2000. 564-577.
  • 3Ramsay LE, Williams B, Johnston GD, et al. Guidclines for management of hypetension: report of the Third working party of the British hypertension, socity [ J ]. J Hum Hypertens , 1999,13:569-592.
  • 4Redon J, Campos C, Narciso ML, et al. Pronostic. Value of amllatory blood pressure monitoring in refractory hypertension: a prospective study [ J ]. Hypertension, 1998,31 : 712- 718.
  • 5Black HR, Bakris GL, Cushman WC, et al. Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study [ J ] . J Clin Hypertens ( Greenwich ) , 2007,9(10) : 760-769.
  • 6Anand I, McMurray J, Cohn JN, et al. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebocontrolled trial. [ J ]. Lancet, 2004,364 ( 9431 ) :347-354.
  • 7Philipp S, Monti J, Page1 I, et al. Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure [ J ]. Clinical Science,2002,103:48.
  • 8Gupta S, Saxena A, Singh U, et al. Bosentan, the mixed ETA-ETB darusentan receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion [ J ]. Molecular and Cellular Biochemistry, 2005,275 (1-2) : 67-74.
  • 9Rosano L, Di Castro V, Spinella F, et al. ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo [ J ]. Molecular Cancer Therapeutics ,2007,6 (7) :2003-2011.
  • 10Masuzawa K, Jesmin S, Maeda S, et al. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin- induced diabetic rat retina [ J ]. Experimental Biology and Medicine, 2006,231 ( 6 ) : 1090-1094.

同被引文献26

  • 1李南方,王磊,周克明,王新玲,祖菲亚,张德莲,张艳敏,常桂娟.新疆维吾尔自治区人民医院住院高血压患者病因构成特点[J].中华心血管病杂志,2007,35(9):865-868. 被引量：29
  • 2Fujita T. Mineralocorticoid receptors, salt -sensitive hypertension, and metabolic syndrome [J]. Hypertension, 2010, 55 (4): 813-818.
  • 3Schmieder RE,Redon J,Grassi G. ESH position paper:renal denervation--an interventional therapy of resistant hypertension[J].{H}Journal of Hypertension,2012,(05):837-841.
  • 4Drager LF,Genta PR,Pedrosa RP. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension[J].{H}American Journal of Cardiology,2010,(08):1135-1139.
  • 5Scheffers IJ,Kroon AA,Schmidli J. Novel baroreflex activation therapy in resistant hypertension:results of a European multi-center feasibility study[J].{H}Journal of the America College of Cardiology,2010,(15):1254-1258.
  • 6Bisognano JD,Kzufman CL,Bach DS. Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension:results from European and United States trials of the Rheos system[J].{H}Journal of the America College of Cardiology,2011,(17):1787-1788.
  • 7Krum H,Schlaich M,Whitbourn R. Catheter-based renal sympathetic denervation for resistant hypertension:a multiccentre safety and proof-of-principle cohort study[J].{H}LANCET,2009,(9671):1275-1281.
  • 8Simplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reducation out to 24 months[J].{H}Hypertension,2011,(05):911-917.
  • 9Esler MD,Krum H,Sobotka PA. Renal sympathetic denervation in patients with treatment-resistant hypertension(The Symplicity HTN-2 Trial):a randomized controlled trial[J].{H}LANCET,2010,(9756):1903-1909.
  • 10赵瑞祥.难治性高血压研究进展[J].中国疗养医学,2009,18(1):87-90. 被引量：11

引证文献2

二级引证文献10

药物流行病学杂志
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部